Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromelalgia.

Mark D P Davis1, Thom Rooke

  • 1Department of Dermatology and the Gonda Vascular Center, Mayo Clinic and Mayo Foundation, 200 First Street, SW, Rochester, MN 55905, USA. davis.mark2@mayo.edu

Current Treatment Options in Cardiovascular Medicine
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plethysmography compared to ultrasound for the evaluation of chronic venous insufficiency.

Vascular medicine (London, England)·2026
Same author

Skinspan<sup>TM</sup>: A Healthy Longevity Framework for Skin Aging.

Mayo Clinic proceedings·2025
Same author

Conjunctival Plaques Leading to Diagnosis of Chronic Lymphocytic Leukemia.

Ophthalmology·2025
Same author

Rapid post exercise venous refilling time is an independent contributor to chronic venous insufficiency.

Journal of vascular surgery. Venous and lymphatic disorders·2025
Same author

Evaluating Copositivity Patterns in Fragrance/Botanical Patch Testing through Hierarchical Clustering and Network Analysis.

Dermatitis : contact, atopic, occupational, drug·2025
Same author

Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010-2023).

Dermatitis : contact, atopic, occupational, drug·2025
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Erythromelalgia management lacks consistent treatments due to limited research. Current approaches involve patient education, symptom relief, and multidisciplinary care, but effective therapies remain elusive.

Area of Science:

  • Medical Science
  • Dermatology
  • Pain Management

Background:

  • Erythromelalgia management presents significant challenges.
  • A lack of robust clinical studies hinders evidence-based treatment recommendations.
  • Current strategies rely heavily on case reports and anecdotal evidence.

Purpose of the Study:

  • To review the current state of erythromelalgia treatment.
  • To highlight the difficulties in managing erythromelalgia.
  • To outline a comprehensive management approach for erythromelalgia patients.

Main Methods:

  • Literature review of existing studies on erythromelalgia treatment.
  • Analysis of case reports and small case series.
  • Synthesis of anecdotal evidence and expert opinion.

Related Experiment Videos

Main Results:

  • No single treatment consistently proves effective for erythromelalgia.
  • Adequate studies evaluating treatment responses are scarce.
  • Management often requires a multidisciplinary approach.

Conclusions:

  • Effective erythromelalgia treatment remains an unmet need.
  • A comprehensive approach including patient education, trigger avoidance, and symptom management is crucial.
  • Further research is essential to develop effective therapies for erythromelalgia.